Analysts’ Viewpoint
Rise in prevalence of valvular heart disease is the major factor driving the global transcatheter heart valve replacement & repair market. Advancements in technology and increase in adoption of these procedures by physicians and patients are expected to propel market development. Ongoing research & development aimed at improving current transcatheter heart valve replacement & repair devices for better patient outcomes are fueling industry progress.
Development of devices that can be fully retrievable after implantation, allowing for greater flexibility and safety during the procedure, offers attractive opportunities for market players. Companies are developing strategies to navigate the regulatory and reimbursement environments in different regions and make their products more accessible to patients.
Transcatheter heart valve replacement & repair refers to a minimally invasive procedure used to replace or repair heart valves that are not functioning properly. This procedure involves inserting a catheter, which is a thin, flexible tube, through a small incision in the skin and threading it through the blood vessels to reach the heart.
Transcatheter heart valve replacement & repair procedures are typically used to treat valvular heart disease, a condition in which heart valves are damaged or not functioning properly. The most common type of valvular heart disease is aortic stenosis, which occurs when the aortic valve becomes narrowed, making it difficult for blood to flow from the heart to the rest of the body.
During the procedure, a new valve is inserted into the heart through the catheter and positioned inside the diseased valve. The new valve then takes over the function of regulating blood flow from the heart. In some cases, the procedure could involve repairing the existing valve using specialized devices inserted through the catheter.
Transcatheter heart valve replacement & repair procedures offer several advantages over traditional open-heart surgery, including reduced recovery time, less pain, and fewer complications. These are also less invasive and can be performed on patients who may not be good candidates for open-heart surgery.
Increase prevalence of cardiovascular diseases is a major driver of the global transcatheter heart valve replacement & repair market size. Cardiovascular disease is a leading cause of death globally, and valvular heart disease is a significant contributor to this burden. Valvular heart disease could occur as a result of age-related degeneration, congenital defects, infections, or other underlying medical conditions.
Transcatheter heart valve replacement and repair procedures offer a less invasive alternative to traditional open-heart surgery, making them a preferred treatment option for patients with valvular heart disease who are at high risk for surgery. Hence, the market has been growing rapidly, driven in part by increase in prevalence of valvular heart disease.
The geriatric population is also contributing to the growth of the market. The risk of developing valvular heart disease increases with age. This propels demand for transcatheter heart valve replacement & repair.
Significant advancements in the development of transcatheter heart valve technologies have been made in the last decade. These advancements have led to the development of new and improved transcatheter heart valve devices that are more durable, safer, and easier to implant.
Some of the technological advancements that have driven the market include development of new materials that are biocompatible & resistant to wear and tear; usage of 3D printing to create customized heart valves; and development of imaging and navigation technologies that enable more precise placement of the heart valve.
Miniaturization of devices is another major technological advancement, which has enabled the development of smaller and more flexible delivery systems for transcatheter heart valves. This has made it possible to perform TAVR medical procedures on a large number of patients, including those with smaller vessels or complex anatomies.
Technological advancements in the field of transcatheter heart valve replacement and repair have led to improved patient outcomes, reduced procedural risks, and increased access to treatment options for patients with valvular heart disease. These factors are expected to accelerate market development in the next few years.
In terms of procedure, the transcatheter aortic valve replacement (TAVR) segment accounted for the largest global transcatheter heart valve replacement & repair market share in 2022. TAVR is a minimally invasive procedure used to replace a diseased or damaged aortic valve without the need for open-heart surgery.
TAVR has been increasingly adopted as a treatment option for patients with severe aortic stenosis who are at high risk for traditional open-heart surgery. Technological advancements, increase in awareness about the benefits of minimally invasive procedures, and aging population have driven the global market in the past few years.
Based on indication, the aortic stenosis segment dominated the global market in 2022. Aortic stenosis is a condition, in which the aortic valve of the heart becomes narrowed, leading to restricted blood flow from the heart to the rest of the body. This could cause symptoms such as chest pain, shortness of breath, and fainting.
Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure that can be used to replace a damaged or diseased aortic valve without open-heart surgery. TAVR has become an increasingly popular treatment option among patients with aortic stenosis, especially for those who are considered to be at high-risk for traditional open-heart surgery.
In terms of end-user, the hospitals segment held significant share of the global market in 2022. Transcatheter heart valve replacement & repair procedures are typically performed in a hospital setting. Hospitals are often the primary point of care for patients with valvular heart disease. Hospitals are also involved in the diagnosis, patient selection, and post-procedural care of patients undergoing transcatheter heart valve replacement & repair procedures. Thus, hospitals play a critical role in the overall patient journey and are an important stakeholder in the market.
However, outpatient transcatheter heart valve replacement & repair procedures are gaining popularity, and there could be a shift toward ambulatory surgery centers (ASCs) and other outpatient settings. This is likely to restrain the hospitals segment in the near future.
As per transcatheter heart valve replacement & repair market trends, North America was the largest market for transcatheter heart valve replacement & repair in 2022. The market in the region is driven by high prevalence of valvular heart disease, increase in adoption of transcatheter heart valve replacement & repair procedures, and favorable reimbursement landscape.
Europe was the second largest market for transcatheter heart valve replacement & repair in 2022. Countries such as Germany, France, and the U.K. accounted for significant share of the market in Europe. The market in Europe is driven by aging population, rise in prevalence of valvular heart disease, and favorable reimbursement policies.
Asia Pacific is likely to be the fastest growing market for transcatheter heart valve replacement & repair during the forecast period. The market in the region is projected to be driven by increase in geriatric population, rise in incidence of valvular heart disease, and improving healthcare infrastructure. China and Japan are expected to be the largest markets in the region.
Expansion of product portfolio and mergers & acquisitions are the key strategies adopted by leading players in the global transcatheter heart valve replacement & repair market. Abbott Laboratories, Edwards Lifesciences Corporation, Medtronic plc, Boston Scientific Corporation, JenaValve Technology, Inc., Meril Life Sciences, Sahajanand Medical Technologies Limited, MicroPort Scientific Corporation, Venus Medtech (Hangzhou), Inc., Suzhou Jiecheng Medical Technology Co. Ltd., Peijia Medical Limited, and Blue Sail Medical Co., Ltd. are the prominent players in the market.
The market report profiles key players based on parameters such as company overview, financial overview, business strategies, portfolio, segments, and recent developments.
|
Attribute |
Detail |
|
Size in 2022 |
US$ 3.4 Bn |
|
Forecast (Value) in 2031 |
More than US$ 8.0 Bn |
|
Growth Rate (CAGR) |
9.7% |
|
Forecast Period |
2023–2031 |
|
Historical Data Available for |
2017–2021 |
|
Quantitative Units |
US$ Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The global industry was valued at US$ 3.4 Bn in 2022.
It is projected to reach more than US$ 8.0 Bn by 2031.
The business is anticipated to advance at a CAGR of 9.7% from 2023 to 2031.
Increase in number of cardiovascular disease patients globally and technological advancements are driving the global market.
North America is projected to account for leading share during the forecast period.
Abbott Laboratories, Edwards Lifesciences Corporation, Medtronic plc, Boston Scientific Corporation, JenaValve Technology, Inc., Meril Life Sciences, Sahajanand Medical Technologies Limited, MicroPort Scientific Corporation, Venus Medtech (Hangzhou), Inc., Suzhou Jiecheng Medical Technology Co. Ltd., Peijia Medical Limited, and Blue Sail Medical Co., Ltd. are the prominent players in the global market.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Transcatheter Heart Valve Replacement & Repair Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Transcatheter Heart Valve Replacement & Repair Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Technological Advancements
5.2. Disease Prevalence & Incidence Rate Globally With Key Countries
5.3. Key Industry Events
5.4. COVID-19 Impact Analysis
6. Global Transcatheter Heart Valve Replacement & Repair Market Analysis and Forecast, by Procedure
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Procedure, 2017–2031
6.3.1. Transcatheter Aortic Valve Replacement (TAVR)
6.3.2. Transcatheter Mitral Valve Repair (TMVR)
6.3.3. Transcatheter Pulmonary Valve Replacement (TPVR)
6.4. Market Attractiveness Analysis, by Procedure
7. Global Transcatheter Heart Valve Replacement & Repair Market Analysis and Forecast, by Indication
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Indication, 2017–2031
7.3.1. Aortic Stenosis
7.3.2. Mitral Regurgitation
7.3.3. Aortic Regurgitation
7.3.4. Mitral Stenosis
7.3.5. Tricuspid Regurgitation
7.4. Market Attractiveness Analysis, by Indication
8. Global Transcatheter Heart Valve Replacement & Repair Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Cardiac Catheterization Laboratories
8.3.3. Ambulatory Surgical Centers
8.4. Market Attractiveness Analysis, by End-user
9. Global Transcatheter Heart Valve Replacement & Repair Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017–2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Transcatheter Heart Valve Replacement & Repair Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Procedure, 2017–2031
10.2.1. Transcatheter Aortic Valve Replacement (TAVR)
10.2.2. Transcatheter Mitral Valve Repair (TMVR)
10.2.3. Transcatheter Pulmonary Valve Replacement (TPVR)
10.3. Market Value Forecast, by Indication, 2017–2031
10.3.1. Aortic Stenosis
10.3.2. Mitral Regurgitation
10.3.3. Aortic Regurgitation
10.3.4. Mitral Stenosis
10.3.5. Tricuspid Regurgitation
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Cardiac Catheterization Laboratories
10.4.3. Ambulatory Surgical Centers
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Procedure
10.6.2. By Indication
10.6.3. By End-user
10.6.4. By Country
11. Europe Transcatheter Heart Valve Replacement & Repair Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Procedure, 2017–2031
11.2.1. Transcatheter Aortic Valve Replacement (TAVR)
11.2.2. Transcatheter Mitral Valve Repair (TMVR)
11.2.3. Transcatheter Pulmonary Valve Replacement (TPVR)
11.3. Market Value Forecast, by Indication, 2017–2031
11.3.1. Aortic Stenosis
11.3.2. Mitral Regurgitation
11.3.3. Aortic Regurgitation
11.3.4. Mitral Stenosis
11.3.5. Tricuspid Regurgitation
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Cardiac Catheterization Laboratories
11.4.3. Ambulatory Surgical Centers
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Procedure
11.6.2. By Indication
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Transcatheter Heart Valve Replacement & Repair Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Procedure, 2017–2031
12.2.1. Transcatheter Aortic Valve Replacement (TAVR)
12.2.2. Transcatheter Mitral Valve Repair (TMVR)
12.2.3. Transcatheter Pulmonary Valve Replacement (TPVR)
12.3. Market Value Forecast, by Indication, 2017–2031
12.3.1. Aortic Stenosis
12.3.2. Mitral Regurgitation
12.3.3. Aortic Regurgitation
12.3.4. Mitral Stenosis
12.3.5. Tricuspid Regurgitation
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Cardiac Catheterization Laboratories
12.4.3. Ambulatory Surgical Centers
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Procedure
12.6.2. By Indication
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Transcatheter Heart Valve Replacement & Repair Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Procedure, 2017–2031
13.2.1. Transcatheter Aortic Valve Replacement (TAVR)
13.2.2. Transcatheter Mitral Valve Repair (TMVR)
13.2.3. Transcatheter Pulmonary Valve Replacement (TPVR)
13.3. Market Value Forecast, by Indication, 2017–2031
13.3.1. Aortic Stenosis
13.3.2. Mitral Regurgitation
13.3.3. Aortic Regurgitation
13.3.4. Mitral Stenosis
13.3.5. Tricuspid Regurgitation
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Cardiac Catheterization Laboratories
13.4.3. Ambulatory Surgical Centers
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Procedure
13.6.2. By Indication
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Transcatheter Heart Valve Replacement & Repair Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Procedure, 2017–2031
14.2.1. Transcatheter Aortic Valve Replacement (TAVR)
14.2.2. Transcatheter Mitral Valve Repair (TMVR)
14.2.3. Transcatheter Pulmonary Valve Replacement (TPVR)
14.3. Market Value Forecast, by Indication, 2017–2031
14.3.1. Aortic Stenosis
14.3.2. Mitral Regurgitation
14.3.3. Aortic Regurgitation
14.3.4. Mitral Stenosis
14.3.5. Tricuspid Regurgitation
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.2. Cardiac Catheterization Laboratories
14.4.3. Ambulatory Surgical Centers
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Procedure
14.6.2. By Indication
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. Abbott Laboratories
15.3.1.1. Company Overview
15.3.1.2. Procedure Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Edwards Lifesciences Corporation
15.3.2.1. Company Overview
15.3.2.2. Procedure Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Boston Scientific Corporation
15.3.3.1. Company Overview
15.3.3.2. Procedure Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. B. Braun Melsungen AG
15.3.4.1. Company Overview
15.3.4.2. Procedure Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Medtronic plc
15.3.5.1. Company Overview
15.3.5.2. Procedure Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Meril Life Sciences
15.3.6.1. Company Overview
15.3.6.2. Procedure Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Sahajanand Medical Technologies Limited
15.3.7.1. Company Overview
15.3.7.2. Procedure Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. MicroPort Scientific Corporation
15.3.8.1. Company Overview
15.3.8.2. Procedure Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Venus Medtech (Hangzhou) Inc.
15.3.9.1. Company Overview
15.3.9.2. Procedure Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Suzhou Jiecheng Medical Technology Co. Ltd.
15.3.10.1. Company Overview
15.3.10.2. Procedure Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
15.3.11. Peijia Medical Limited
15.3.11.1. Company Overview
15.3.11.2. Procedure Portfolio
15.3.11.3. SWOT Analysis
15.3.11.4. Financial Overview
15.3.11.5. Strategic Overview
15.3.12. Blue Sail Medical Co., Ltd.
15.3.12.1. Company Overview
15.3.12.2. Procedure Portfolio
15.3.12.3. SWOT Analysis
15.3.12.4. Financial Overview
15.3.12.5. Strategic Overview
List of Tables
Table 01: Global Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by Procedure, 2017–2031
Table 02: Global Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by Indication, 2017–2031
Table 03: Global Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by Procedure, 2017–2031
Table 07: North America Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by Indication, 2017–2031
Table 08: North America Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: Europe Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by Procedure, 2017–2031
Table 11: Europe Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by Indication, 2017–2031
Table 12: Europe Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Asia Pacific Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by Procedure, 2017–2031
Table 15: Asia Pacific Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by Indication, 2017–2031
Table 16: Asia Pacific Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 17: Latin America Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by Procedure, 2017–2031
Table 19: Latin America Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by Indication, 2017–2031
Table 20: Latin America Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Middle East & Africa Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Middle East & Africa Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by Procedure, 2017–2031
Table 23: Middle East & Africa Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by Indication, 2017–2031
Table 24: Middle East & Africa Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) and Distribution (%), by Region, 2022 and 2031
Figure 02: Global Transcatheter Heart Valve Replacement & Repair Market Revenue (US$ Mn), by Procedure, 2022
Figure 03: Global Transcatheter Heart Valve Replacement & Repair Market Value Share, by Procedure, 2022
Figure 04: Global Transcatheter Heart Valve Replacement & Repair Market Revenue (US$ Mn), by Indication, 2022
Figure 05: Global Transcatheter Heart Valve Replacement & Repair Market Value Share, by Indication, 2022
Figure 06: Global Transcatheter Heart Valve Replacement & Repair Market Revenue (US$ Mn), by End-user, 2022
Figure 07: Global Transcatheter Heart Valve Replacement & Repair Market Value Share, by End-user, 2022
Figure 08: Global Transcatheter Heart Valve Replacement & Repair Market Value Share, by Region, 2022
Figure 09: Global Transcatheter Heart Valve Replacement & Repair Market Value (US$ Mn) Forecast, 2017–2031
Figure 10: Global Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by Procedure, 2022 and 2031
Figure 11: Global Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by Procedure, 2023-2031
Figure 12: Global Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by Indication, 2022 and 2031
Figure 13: Global Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by Indication, 2023-2031
Figure 14: Global Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by End-user, 2022 and 2031
Figure 15: Global Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by End-user, 2023-2031
Figure 16: Global Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by Region, 2022 and 2031
Figure 17: Global Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by Region, 2023-2031
Figure 18: North America Transcatheter Heart Valve Replacement & Repair Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 19: North America Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by Country, 2017–2031
Figure 20: North America Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by Country, 2022 and 2031
Figure 21: North America Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by Procedure, 2022 and 2031
Figure 22: North America Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by Indication, 2022 and 2031
Figure 23: North America Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by End-user, 2022 and 2031
Figure 24: North America Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by Procedure, 2023–2031
Figure 25: North America Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by Indication, 2023–2031
Figure 26: North America Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by End-user, 2023-2031
Figure 27: Europe Transcatheter Heart Valve Replacement & Repair Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 28: Europe Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by Country/Sub-region, 2017–2031
Figure 29: Europe Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 30: Europe Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by Procedure, 2022 and 2031
Figure 31: Europe Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by Indication, 2022 and 2031
Figure 32: Europe Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by End-user, 2022 and 2031
Figure 33: Europe Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by Procedure, 2023–2031
Figure 34: Europe Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by Indication, 2023–2031
Figure 35: Europe Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by End-user, 2023–2031
Figure 36: Asia Pacific Transcatheter Heart Valve Replacement & Repair Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 37: Asia Pacific Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by Country/Sub-region, 2017–2031
Figure 38: Asia Pacific Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 39: Asia Pacific Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by Procedure, 2022 and 2031
Figure 40: Asia Pacific Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by Indication, 2022 and 2031
Figure 41: Asia Pacific Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by End-user, 2022 and 2031
Figure 42: Asia Pacific Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by Procedure, 2023–2031
Figure 43: Asia Pacific Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by Indication, 2023–2031
Figure 44: Asia Pacific Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by End-user, 2023–2031
Figure 45: Latin America Transcatheter Heart Valve Replacement & Repair Market Value(US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 46: Latin America Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by Country/Sub-region, 2017–2031
Figure 47: Latin America Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 48: Latin America Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by Procedure, 2022 and 2031
Figure 49: Latin America Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by Indication, 2022 and 2031
Figure 50: Latin America Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by End-user, 2022 and 2031
Figure 51: Latin America Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by Procedure, 2023–2031
Figure 52: Latin America Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by Indication, 2023–2031
Figure 53: Latin America Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by End-user, 2023–2031
Figure 54: Middle East & Africa Transcatheter Heart Valve Replacement & Repair Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 55: Middle East & Africa Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by Country/Sub-region, 2017–2031
Figure 56: Middle East & Africa Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 57: Middle East & Africa Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by Procedure, 2022 and 2031
Figure 58: Middle East & Africa Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by Indication, 2022 and 2031
Figure 59: Middle East & Africa Transcatheter Heart Valve Replacement & Repair Market Value Share Analysis, by End-user, 2022 and 2031
Figure 60: Middle East & Africa Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by Procedure, 2023–2031
Figure 61: Middle East & Africa Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by Indication, 2023–2031
Figure 62: Middle East & Africa Transcatheter Heart Valve Replacement & Repair Market Attractiveness Analysis, by End-user, 2023–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Transcatheter Heart Valve Replacement and Repair Market
*86 figures and 60 tables includes